PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
34057116-3	2021	OBJECTIVE: This study aimed to investigate the correlation between plasma levels of ALDH1 and chemotherapy responses to the taxane-adriamycin-cyclophosphamide (TAC) regimen in breast cancer patients.	tac	160-163	aldehyde dehydrogenase 1 family member A1	Homo sapiens	84-89	
34057116-10	2021	A change in the ALDH1 levels was observed after the third cycle of TAC administration, with significantly higher ALDH1 levels observed in responsive compared with non-responsive patients (p < 0.05).	tac	67-70	aldehyde dehydrogenase 1 family member A1	Homo sapiens	16-21	
34057116-10	2021	A change in the ALDH1 levels was observed after the third cycle of TAC administration, with significantly higher ALDH1 levels observed in responsive compared with non-responsive patients (p < 0.05).	tac	67-70	aldehyde dehydrogenase 1 family member A1	Homo sapiens	113-118	
34057116-11	2021	CONCLUSION: The results of this study may indicate a role for ALDH1 in chemoresponsiveness, rather than chemoresistance, for the TAC regimen in breast cancer patients.	tac	129-132	aldehyde dehydrogenase 1 family member A1	Homo sapiens	62-67